Idraparinux and liver enzymes
- 1 January 2003
- journal article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 14 (1), 61-65
- https://doi.org/10.1097/00001721-200301000-00011
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Delayed-Onset Heparin-Induced ThrombocytopeniaAnnals of Internal Medicine, 2002
- Antithrombotic Therapy for Venous Thromboembolic DiseaseChest, 2001
- Mortality of Untreated Deep Vein Thrombosis Following Knee ArthroscopyChest, 1999
- Reinstituting warfarin in patients who develop warfarin skin necrosisAmerican Journal of Hematology, 1996
- Acenocoumarol and Heparin Compared with Acenocoumarol Alone in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1992
- A prospective study of the incidence of deep‐vein thrombosis within a defined urban populationJournal of Internal Medicine, 1992
- Adverse effects of three different forms of heparin therapy: thrombocytopenia, increased transaminases, and hyperkalaemiaEuropean Journal of Clinical Pharmacology, 1989
- Transaminasenanstieg: eine weitgehend unbekannte Nebenwirkung der HeparintherapieDeutsche Medizinische Wochenschrift (1946), 1980
- Serum Aminotransferases after Low‐Dose Heparin TreatmentActa Medica Scandinavica, 1978
- Hyper-transaminasemia with heparin therapy.BMJ, 1975